References:
1. ”Cancer Stat Facts: Myeloma.” Surveillance, Epidemiology, and End Results Program. Surveillance, Epidemiology, and End Results Program, 2021.
2. Siegel, R.L., et al., Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians, 2021. 71 (1): p. 7-33.
3. Chen, H.F., et al., Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance. Onco Targets Ther, 2012. 5 : p. 329-34.
4. Birjawi, G.A., et al., Abdominal manifestations of multiple myeloma: a retrospective radiologic overview. Clin Lymphoma Myeloma, 2008. 8 (6): p. 348-51.
5. Babu, G., et al., Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India, 2017. 34 (2): p. 176-178.
6. Yokoyama, T., et al., Multiple myeloma presenting initially with pleural effusion and a unique paraspinal tumor in the thorax.Intern Med, 2008. 47 (21): p. 1917-20.
7. Mitra, S., et al., IgG Lambda Myeloma Presenting as Plasmacytic Ascites: Case Report and Review of Literature. Indian J Hematol Blood Transfus, 2015. 31 (4): p. 472-9.
8. Abdulsamad, M., et al., Immunoglobulin A Lambda Multiple Myeloma in a Patient with HIV: An Unusual Cause of Massive Ascites.Case Rep Gastroenterol, 2017. 11 (1): p. 201-206.
9. Damaj, G., et al., Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center.European Journal of Haematology, 2004. 73 (6): p. 402-406.
10. Gochhait, D., P. Dey, and N. Verma, Cytology of plasma cell rich effusion in cases of plasma cell neoplasm. Journal of cytology, 2016. 33 (3): p. 150-153.
11. Lang, K.J., S. Lidder, and R. Aitchison, Massive pleural effusion due to IgG multiple myeloma. Hematology Reviews, 2009.1 (2): p. e18.
12. Kamble, R., et al., Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma, 2005.46 (8): p. 1137-42.
13. Alukal, J., J. Laster, and A. Thomas, Multiple Myeloma Manifesting as Acute Ascites: 2300. Official journal of the American College of Gastroenterology | ACG, 2017. 112 : p. S1259.
14. Chang, H., et al., Myelomatous pleural effusion in a patient with plasmablastic myeloma: a case report. Diagn Cytopathol, 2009.37 (3): p. 205-7.
15. Stoos-Veic, T., et al., Myelomatous ascites in a patient with liver cirrhosis: A case report. Diagn Cytopathol, 2009.37 (10): p. 780-2.
16. Ghorbel, I.B., et al., Pleural myelomatous involvement in multiple myeloma: five cases. Ann Saudi Med, 2015. 35 (4): p. 327-30.
17. Kumar, S., T. Kimlinger, and W. Morice, Immunophenotyping in multiple myeloma and related plasma cell disorders. Best Pract Res Clin Haematol, 2010. 23 (3): p. 433-51.
18. Inoue, Y., et al., Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites. Leukemia Research, 2005. 29 (6): p. 715-718.
19. Alegre, A., C. Martínez-Chamorro, and J.M. Fernández-Rañada,Massive myelomatous ascites responsive to VAD chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant, 1999.24 (3): p. 343-4.
20. Sekiguchi, Y., et al., Response to low-dose bortezomib in plasma cell leukemia patients with malignant pleural effusion and ascites: a case report and a review of the literature. Intern Med, 2012. 51 (11): p. 1393-8.
21. Singh, D. and L. Kumar, Myelomatous ascites in multiple myeloma. Leuk Lymphoma, 2005. 46 (4): p. 631-2.